| Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study G Giaccone, C Kim, J Thompson, C McGuire, B Kallakury, JJ Chahine, ... The Lancet Oncology 19 (3), 347-355, 2018 | 342 | 2018 |
| Refining the treatment of NSCLC according to histological and molecular subtypes A Thomas, SV Liu, DS Subramaniam, G Giaccone Nature reviews Clinical oncology 12 (9), 511-526, 2015 | 309 | 2015 |
| Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. S Jonna, DS Subramaniam Discovery medicine 27 (148), 167-170, 2019 | 216 | 2019 |
| Utilizing prognostic and predictive factors in breast cancer DS Subramaniam, C Isaacs Current treatment options in oncology 6, 147-159, 2005 | 117 | 2005 |
| CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance KS Park, M Raffeld, YW Moon, L Xi, C Bianco, T Pham, LC Lee, ... The Journal of clinical investigation 124 (7), 3003-3015, 2014 | 108 | 2014 |
| Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells SJ Dovedi, MJ Elder, C Yang, SI Sitnikova, L Irving, A Hansen, J Hair, ... Cancer Discovery 11 (5), 1100-1117, 2021 | 105 | 2021 |
| Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer BT Collins, S Vahdat, K Erickson, SP Collins, S Suy, X Yu, Y Zhang, ... Journal of hematology & oncology 2, 1-9, 2009 | 93 | 2009 |
| Targetable gene fusions associate with the IDH wild-type astrocytic lineage in adult gliomas SD Ferguson, S Zhou, JT Huse, JF de Groot, J Xiu, DS Subramaniam, ... Journal of Neuropathology & Experimental Neurology 77 (6), 437-442, 2018 | 86 | 2018 |
| Characterization of atherosclerotic plaques at the carotid bifurcation: correlation of high-resolution MR imaging with histologic analysis--preliminary study. G Von Ingersleben, UP Schmiedl, TS Hatsukami, JA Nelson, ... Radiographics 17 (6), 1417-1423, 1997 | 85 | 1997 |
| Management of brain metastases in epidermal growth factor receptor mutant non-small-cell lung cancer WJ Kelly, NJ Shah, DS Subramaniam Frontiers in oncology 8, 208, 2018 | 81 | 2018 |
| A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies JF Deeken, R Slack, GJ Weiss, RK Ramanathan, MJ Pishvaian, J Hwang, ... Cancer chemotherapy and pharmacology 71, 627-633, 2013 | 81 | 2013 |
| Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial DA Reardon, TM Kim, JS Frenel, M Simonelli, J Lopez, DS Subramaniam, ... Cancer 127 (10), 1620-1629, 2021 | 77 | 2021 |
| A phase Ib/II study of XL184 (BMS 907351) with and without erlotinib (E) in patients (pts) with non-small cell lung cancer (NSCLC). HA Wakelee, SN Gettinger, JA Engelman, PA Janne, HJ West, ... Journal of Clinical Oncology 28 (15_suppl), 3017-3017, 2010 | 73 | 2010 |
| CyberKnife for hilar lung tumors: report of clinical response and toxicity K Unger, A Ju, E Oermann, S Suy, X Yu, S Vahdat, D Subramaniam, ... Journal of hematology & oncology 3, 1-7, 2010 | 71 | 2010 |
| Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with K RAS‐activated tumors MA Villalona‐Calero, E Lam, GA Otterson, W Zhao, M Timmons, ... Cancer 122 (6), 875-883, 2016 | 69 | 2016 |
| Biomarkers in early-stage non–small-cell lung cancer: current concepts and future directions M Burotto, A Thomas, D Subramaniam, G Giaccone, A Rajan Journal of Thoracic Oncology 9 (11), 1609-1617, 2014 | 68 | 2014 |
| Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung C Kim, SV Liu, DS Subramaniam, T Torres, M Loda, G Esposito, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 56 | 2020 |
| A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small … AA Chiappori, MT Schreeder, MM Moezi, JJ Stephenson, J Blakely, ... British journal of cancer 106 (5), 839-845, 2012 | 53 | 2012 |
| ATIM-35. Results of the phase IB KEYNOTE-028 multi-cohort trial of pembrolizumab monotherapy in patients with recurrent PD-L1-positive glioblastoma multiforme (GBM) DA Reardon, TM Kim, JS Frenel, A Santoro, J Lopez, DS Subramaniam, ... Neuro-Oncology 18 (suppl_6), vi25-vi26, 2016 | 51 | 2016 |
| Atherosclerosis of the carotid artery: evaluation by magnetic resonance angiography KS Wildy, C Yuan, JS Tsuruda, MS Ferguson, N Wen, DS Subramaniam, ... Journal of Magnetic Resonance Imaging 6 (5), 726-732, 1996 | 42 | 1996 |
